Skip to main content

Advertisement

SpringerLink
Log in

Ticagrelor, a New Antiplatelet Agent, for Prevention of Ischemic Events in Patients with Coronary Artery Disease

  • Clinical Trial Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sacco RL, Adams R, Albers G, et al.: Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37:577–617.

    Article  PubMed  Google Scholar 

  2. Michelson AD: New P2Y12 antagonists. Curr Opin Hematol 2009, 16:371–377.

    Article  CAS  PubMed  Google Scholar 

  3. Storey RF, Melissa Thornton S, Lawrance R, et al.: Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3. Platelets 2009, 20:341–348.

    Article  CAS  PubMed  Google Scholar 

  4. Diener HC, Bogousslavsky J, Brass LM, et al.: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004, 364:331–337.

    Article  CAS  PubMed  Google Scholar 

  5. Kennedy J, Hill MD, Ryckborst KJ, et al.: Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007, 6:961–969.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

Dr. Adams has received research support from Merck, NMT Medical, and Schering-Plough.

Author information

Authors and Affiliations

  1. Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa Stroke Center, University of Iowa, 200 Hawkings Drive, Iowa City, IA, 52242, USA

    Harold P. Adams Jr.

Authors
  1. Harold P. Adams Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harold P. Adams Jr..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adams, H.P. Ticagrelor, a New Antiplatelet Agent, for Prevention of Ischemic Events in Patients with Coronary Artery Disease. Curr Neurol Neurosci Rep 10, 4–6 (2010). https://doi.org/10.1007/s11910-009-0082-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-009-0082-x

Keywords

Search

Navigation